sulfadiazine has been researched along with methylprednisolone in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (16.67) | 18.7374 |
1990's | 2 (11.11) | 18.2507 |
2000's | 7 (38.89) | 29.6817 |
2010's | 6 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Adler, JL; Bach, MC; Breman, J; Madras, P; Monaco, AP; P'eng, F; Sahyoun, A; Schlesinger, RM | 1 |
DeLemos, RA; Haggerty, RJ | 1 |
Couvreur, J; Desmonts, C | 1 |
Añíbarro, B; Fontela, JL | 1 |
Coll, O; Costa, J; Falgueras, T; Gómez-López, L; Pujol-Riqué, M; Rodríguez-Miguélez, JM; Tudó, G; Valls, ME | 1 |
Mäkelä, S; Pasternack, A; Saha, H | 1 |
Fong, KS; Hsu, LY; Lee, MW; Lim, WK | 1 |
Aksoy, A; Oguz, M; Ozkan, M; Tanir, G; Yıldız, YT | 1 |
1 review(s) available for sulfadiazine and methylprednisolone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for sulfadiazine and methylprednisolone
Article | Year |
---|---|
Corticosteroids as an adjunct to treatment in bacterial meningitis. A controlled clinical trial.
Topics: Bacteria; Child; Chloramphenicol; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Male; Meningitis; Meningitis, Haemophilus; Meningitis, Meningococcal; Meningitis, Pneumococcal; Methylprednisolone; Penicillins; Placebos; Sulfadiazine | 1969 |
16 other study(ies) available for sulfadiazine and methylprednisolone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
High incidence of fungus infections in renal transplantation patients treated with antilymphocyte and conventional immunosuppression.
Topics: Amphotericin B; Antilymphocyte Serum; Aspergillus; Azathioprine; Cryptococcus neoformans; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Methylprednisolone; Mycoses; Nocardia; Prednisone; Sulfadiazine; Transplantation, Homologous | 1973 |
[Treatment of congenital toxoplasmosis].
Topics: Antibodies; Child; Child, Preschool; Drug Therapy, Combination; Folic Acid; Humans; Infant; Leucomycins; Methylprednisolone; Prednisone; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Congenital | 1983 |
Sulfadiazine-induced sialadenitis.
Topics: Anti-Infective Agents; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Sialadenitis; Sulfadiazine | 1997 |
[Analysis of a case of severe congenital toxoplasmosis].
Topics: Acute Disease; Administration, Topical; Adult; Animals; Anti-Inflammatory Agents; Antibodies, Protozoan; Antiprotozoal Agents; Blood; Brain; Cerebrospinal Fluid; Chorioretinitis; Dexamethasone; Female; Glucocorticoids; Humans; Infant, Newborn; Leucovorin; Male; Methylprednisolone; Mice; Neonatal Screening; Ophthalmic Solutions; Polymerase Chain Reaction; Pregnancy; Pyrimethamine; Random Amplified Polymorphic DNA Technique; Sulfadiazine; Tomography, X-Ray Computed; Toxoplasma; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular | 1999 |
[Atrioventricular block in a young man].
Topics: Adult; Anti-Inflammatory Agents; Cyclophosphamide; Drug Combinations; Granulomatosis with Polyangiitis; Heart Block; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Pacemaker, Artificial; Sulfadiazine; Trimethoprim | 2000 |
Optic nerve toxoplasmosis and orbital inflammation as initial presentation of AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Blepharitis; CD4 Lymphocyte Count; Conjunctivitis; Drug Therapy, Combination; HIV Seropositivity; Humans; Leucovorin; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Optic Nerve Diseases; Orbital Pseudotumor; Pyrimethamine; Retinal Vein Occlusion; Sulfadiazine; Toxoplasmosis, Ocular | 2006 |
Acute disseminated encephalomyelitis associated with acute Toxoplasma gondii Infection.
Topics: Brain; Child; Coccidiostats; Encephalomyelitis, Acute Disseminated; Glucocorticoids; Humans; Male; Methylprednisolone; Prednisolone; Pyrimethamine; Spinal Cord; Sulfadiazine; Toxoplasma; Toxoplasmosis; Treatment Outcome | 2013 |